The past 12 months have brought significant and radical change in the healthcare industry. The following are some of the top stories of 2012 revisited.
The past 12 months have brought significant and radical change in the healthcare industry. Here are some of the top stories of 2012 revisited.
The top story of 2012 was unquestionably the Supreme Court’s decision to uphold the 2010 Patient Protection and Affordable Care Act (PPACA). By joining the four liberal justices on the court, Chief Justice John G. Roberts Jr. provided the key vote that upheld the individual mandate, the key piece of the PPACA, requiring Americans to purchase health insurance. The mandate was deemed constitutional under Congress’ power to lay and collect taxes.
Aside from the historical significance, the decision brought with it a plethora of additional considerations. For instance, medical spending and quality of care were two major focal points following the Supreme Court’s decision. States were left to ponder the pros and cons of Medicaid Expansion. Additionally, individual states were also left to grapple with the decision of whether or not to implement their own health insurance exchange (HIX). Even today, legislative and economic challenges still exist, causing some states to refuse any part in setting up a HIX, while others continue to move forward thanks to government grants.
But beyond the fallout from the Supreme Court’s decision, there were many other significant stories in managed care in 2012. Some of those include the following:
Finally, the past year included many managed care conferences that brought with them new data on revenue models, cost savings, personalized medicine, and much more. The AJMC editorial team had the privilege of covering many of these conferences on site to bring the latest information to readers. Here are some of the highlights:
The past 12 months have brought about an unprecedented amount of change in the healthcare arena. In many instances, change is just beginning, meaning that 2013 and beyond will bring about continued change, as stakeholders from all sectors of the healthcare industry come together to examine new strategies to deliver better care while reducing costs. As always, we look forward to bringing you the latest information as the industry continues to evolve.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More